Companies news

Hayes Lemmerz International, Inc. Realigns Global Operations

NORTHVILLE, Michigan, September 18 /PRNewswire/ --

Hayes Lemmerz International, Inc. ("Hayes" or the "Company") announced today that effective September 1, 2009, the Company realigned its global operational sites into three regions.

Fred Bentley, President and Chief Operating Officer, stated, "The purpose of the realignment is to become more strategically focused in the operation of the business by aligning the organization into specific regions. This realignment allows us to continue our global focus on the customer base while creating additional efficiencies from the functional support groups. This is a great move for our business and allows us to continue to develop our future leaders."

The organization will be aligned into three regions.

The first region is Turkey.

Mustafa Zaim - Managing Director of Turkish Operations will continue in his present role as Managing Director and will also assume the additional responsibilities coordinating Global Materials management as well as act in an Advisory capacity to the EAAP region on operational matters. Zaim will continue to report to Mr. Bentley.

The second region is Europe, Africa and Asia Pacific (EAAP).

Pieter Klinkers - Vice President Sales & Marketing has been promoted to President - Europe, Africa & Asia Pacific.

David Kasul - Managing Director - Brazil has been promoted to Vice President - Operations for Europe and Africa.

Marc Hendrickx will replace Klinkers in the role of Vice President - Sales & Marketing.

The third region is "The Americas" which consists of North America, Mexico and Brazil.

Donald Hampton - Vice President - North American Wheels Group has been promoted to Vice President and General Manager for the Americas.

Luis Blecher - Financial Director - Brazil has been promoted to Managing Director of Brazil to replace David Kasul and will be responsible for all Brazilian operations.

About Hayes Lemmerz International, Inc.

Originally founded in 1908, Hayes Lemmerz International, Inc. is a leading worldwide producer of aluminum and steel wheels for passenger cars and light trucks and of steel wheels for commercial trucks and trailers. The Company is also a supplier of automotive powertrain components. The Company has global operations with 23 facilities, including business, sales offices and manufacturing facilities, located in 12 countries around the world. The Company sells products to every major North American, Asian and European manufacturer of passenger cars and light trucks and to commercial highway vehicle customers throughout the world.

Hayes Lemmerz International, Inc.

Eric Moraw, Hayes Lemmerz International, +1-734-737-5679

TOR Minerals Announces Receipt of Nasdaq Staff Deficiency Letter Related to Minimum Bid Price

CORPUS CHRISTI, Texas, Sept. 18 /PRNewswire-FirstCall/ -- TOR Minerals International (the "Company") , producer of synthetic titanium dioxide and color pigments, specialty aluminas, and other high performance mineral fillers, today announced receipt of a Staff Deficiency Letter, dated September 15, 2009, from Nasdaq indicating that the Company fails to comply with the "Minimum Bid Price" requirement for continued listing set forth in Listing Rule 5550(a)(2) (the "Rule").

The Rule requires listed securities to maintain a minimum bid price of $1.00 per share. Based upon the closing bid price for the last 30 consecutive business days through September 14, 2009, the Company no longer meets this requirement. Consequently, a deficiency exists with regard to the Rule. However, the Rules also provide the Company with a grace period of 180 calendar days, or until March 15, 2010, in which to regain compliance.

If at anytime during this grace period the bid price of the Company's security closes at $1.00 per share or more for a minimum of ten consecutive business days, Nasdaq will provide the Company written confirmation of compliance and this matter will be closed.

In the event the Company does not regain compliance with the Rule prior to the expiration of the grace period on March 15, 2010, it will receive written notification that its securities are subject to delisting. At that time, the Company may appeal the delisting determination to a hearing's panel. Alternatively, the Company may be eligible for an additional grace period if it meets the initial listing standards, with the exception of bid price, for The Nasdaq Capital Market. If it meets the initial listing criteria, Nasdaq will notify the Company that it has been granted an additional 180 calendar day compliance period.

Headquartered in Corpus Christi, Texas, TOR Minerals International is a global manufacturer and marketer of specialty mineral and pigment products for high performance applications with manufacturing and regional offices located in the United States, Netherlands and Malaysia.

This statement provides forward-looking information as that term is defined in the Private Securities Litigation Reform Act of 1995, and, therefore, is subject to certain risks and uncertainties. There can be no assurance that the actual results, business conditions, business developments, losses and contingencies and local and foreign factors will not differ materially from those suggested in the forward-looking statements as a result of various factors, including market conditions, general economic conditions, including the present slow down in U.S. construction and the risks of a general business slow down or recession, the increasing cost of energy, raw materials and labor, competition, the receptivity of the markets for our anticipated new products, advances in technology, changes in foreign currency rates, freight price increase, commodity price increases, delays in delivery of required equipment, the possibility that the Company's common stock may be delisted by Nasdaq and other factors.

Contact for Further Information: David Mossberg Three Point Advisors, LLC (817) 310-0051

TOR Minerals International

CONTACT: David Mossberg of Three Point Advisors, LLC, +1-817-310-0051,
for TOR Minerals International

Web Site: http://www.torminerals.com/

Solta Medical to Present at the Maxim Group Growth Conference

HAYWARD, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Solta Medical, Inc. , a global leader in the medical aesthetics market, today announced that it will present at the Maxim Group Growth Conference to be held on Tuesday, September 29, 2009 at the Grand Hyatt New York Hotel in New York, NY. The Company's presentation is scheduled for 10:30 a.m. Eastern Time on September 29, 2009. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events.

Solta will offer a live audio webcast of its presentation which may be accessed at the Investor Relations section of the Company's website at http://www.solta.com/. An archived replay of the presentation will be available until October 15, 2009, also at http://www.solta.com/.

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians.

The company offers products to address aging skin under the industry's two premier brands: Thermage and Fraxel . Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, over one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to http://www.solta.com/.

Solta Medical, Inc.

CONTACT: Jack Glenn, Chief Financial Officer of Solta Medical, Inc.,
+1-510-786-6890; Investors, Doug Sherk or Jenifer Kirtland,
jkirtland@evcgroup.com, both of EVC Group, +1-415-896-6820, for Solta Medical,
Inc.

Web Site: http://www.solta.com/

Wataire Hires Hilbroy Advisory as Its Corporate Finance Advisors

WOODLAND HILLS, CA, Sept. 18 /PRNewswire-FirstCall/ -- Wataire International Inc. (PinkSheets:WTAR) announced today the hiring of Hilbroy Advisory as its corporate finance advisors.

According to the company, since 2000, Hilbroy Advisory has helped publicly and privately held corporations raise funds through institutional investors and accredited investors. The initial task of Hilbroy Advisory will be to manage all disclosure requirements and the company's securities awareness campaign.

About Hilbroy Advisory Inc.

Hilbroy Advisory Inc. is a Canadian-based advisory and consultancy company founded in September 2000. Hilbroy provides publicly traded and private companies, institutions and individuals with a series of advisory services enabling these companies to fully reach their corporate objectives and potential. The company's head office is located in Montreal, Canada. http://www.hilbroyadvisory.com/ Hilbroy has secured its international position through affiliate offices in London, Zurich and soon Moscow and Hong Kong. Hilbroy has established numerous international relationships over the years with Broker Dealers, Hedge Funds, Institutional Investors, High net worth Investors as well as with Investor Relations firms and consultants.

About Wataire International Inc:

Wataire International Inc. is an International Company focused on developing and delivering technology-based water harvesting and purification products worldwide. Wataire is a manufacturer of innovative drinking water treatment systems such as atmospheric water generators and filtration systems. It provides innovative water supply solutions that are especially suitable for areas that may have no alternative sources of potable drinking water. The atmospheric generator produces purified water from the atmosphere by using a special filtration system that removes dust, airborne particles, etc. to generate pure, safe drinking water, and at the same time, simultaneously cleans the air we breathe. This method of extracting water vapor has been in use for many years and generations. Wataire's atmospheric water generation products are presently delivered in the 1,000's and in over 30 countries around the world.

For more information about WTAR visit: http://www.watair.com/ Forward-looking Statement:

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995 - forward-looking statements concerning plans, objectives, goals, strategies, future events of performance and underlying assumptions and other statements which are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and services demand and acceptance, changes in technology and in economic, political and regulatory conditions and to all of the risks generally associated with a company at Watair's stage of development. All such forward looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by these cautionary statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Wataire international Inc. (WTAR)

CONTACT: Wataire International Inc., info@watair.com, Tel.
1-877-602-8985

Aehr Test Systems Receives Nasdaq Notification Related to Minimum Bid Price Rule

FREMONT, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Aehr Test Systems , a technology leader in the semiconductor test and burn-in equipment industry, today announced that on September 15, 2009 the Company received a letter from the Nasdaq Stock Market ("Nasdaq") notifying the Company that it no longer complies with Rule 5450 (a)(1) (the "Minimum Bid Price Rule"), as the bid price of the Company's shares closed below the minimum $1.00 per share for the 30 consecutive business days prior to the date of the letter. In accordance with Rule 5810 (c)(3)(A) (the "Grace Period Rule"), the Company will be provided 180 calendar days, or until March 15, 2010, to regain compliance with the Minimum Bid Price Rule. The deficiency letter has no effect on the listing of the Company's common stock at this time and its shares will continue to trade on the Nasdaq Global Market under the symbol "AEHR".

If at any time before March 15, 2010, the bid price of the Company's stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, Nasdaq will notify the Company that it has achieved compliance with the Minimum Bid Price Rule and the matter will be closed. In the event the Company does not regain compliance with the Minimum Bid Price Rule prior to the expiration of the grace period, it will receive written notification that its common stock is subject to delisting. Alternatively, the Company may be eligible for an additional grace period if it meets the initial listing standards, with the exception of the Minimum Bid Price Rule, for the Nasdaq Capital Market. To avail itself of this alternative, the Company will need to submit an application to transfer its common stock to the Nasdaq Capital Market.

The Company plans to exercise diligent efforts to maintain the listing of its common stock on the Nasdaq Global Market, or alternatively, to transfer its common stock to the Nasdaq Capital Market, but there is no assurance that it will be successful in doing so.

About Aehr Test Systems

Headquartered in Fremont, California, Aehr Test Systems is a leading worldwide provider of systems for burning-in and testing DRAMs, flash, and other memory and logic integrated circuits and has an installed base of more than 2,500 systems worldwide. Aehr Test has developed and introduced several innovative products, including the ABTS(TM), FOX(TM), MTX and MAX systems and the DiePak carrier. The ABTS is Aehr Test's newest system for packaged part test during burn-in for both low-power and high-power logic as well as all common types of memory devices. The FOX system is a full wafer contact test and burn-in system. The MTX system is a massively parallel test system designed to reduce the cost of memory testing by performing both test and burn-in on thousands of devices simultaneously. The MAX system can effectively burn-in and functionally test complex devices, such as digital signal processors, microprocessors, microcontrollers and systems-on-a-chip. The DiePak carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of bare die. For more information, please visit the Company's website at http://www.aehr.com/.

Safe Harbor Statement

This release contains forward-looking statements that involve risks and uncertainties relating to projections regarding revenues and customer demand and acceptance of Aehr Test's products. Actual results may vary from projected results. These risks and uncertainties include without limitation, world economic conditions, the timing of the recovery of the semiconductor equipment market, the Company's ability to maintain sufficient cash to support operations, acceptance by customers of Aehr Test's technologies, acceptance by customers of the systems shipped upon receipt of a purchase order and the ability of new products to meet customer needs or perform as described, and the Company's development and manufacture of a commercially successful wafer-level test and burn-in system. See Aehr Test's recent 10-K and other reports from time to time filed with the U.S. Securities and Exchange Commission for a more detailed description of the risks facing our business. The Company disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

Contact: Lasse Glassen Financial Relations Board for Aehr Test Systems Investor/Analyst Contact (213) 486-6546

Aehr Test Systems

CONTACT: Investors/Analysts, Lasse Glassen of Financial Relations Board,
+1-213-486-6546, for Aehr Test Systems

Web Site: http://www.aehr.com/

Morgan Stanley ups 2012 Oil Forecast to $105LUXE: OTC-BB

SINGAPORE, Sept. 18 /PRNewswire-FirstCall/ -- Reuters Last updated on Monday, Sep. 14, 2009 09:23AM EDT

Morgan Stanley has raised its forecast of U.S. crude oil price to $105 (U.S.) a barrel in 2012 from $95 due to tightening spare capacity, the U.S. bank said in a research note seen on Monday.

It expected global spare production capacity to stay ample through end-2010, before declining in 2011 and reaching 2007/08-like tightness by 2012.

"Assuming that demand returns to growth, we see global spare capacity back to 2007/08 levels by 2012, and getting even tighter thereafter," Morgan Stanley said.

"We believe that prices will need to move higher to ration demand as the world struggles to find enough supply," it said, adding that the research was based on the bank's proprietary database of more than 460 fields expected to come online through 2015.

International benchmark U.S. crude (CL-FT70.62-0.31-0.44%) peaked above $147 in July 2008 on strong demand from emerging economies such as China.

But the global economic recession has curtailed energy demand and slashed oil prices, which have traded around $68 to $71 a barrel over the last week. Morgan Stanley assumes oil demand will fall by 2 million barrels per day (bpd) this year, rebound by 1 million bpd in 2010 and then grow by just 1 per cent, it said.

Post 2012, global liquids production shows the potential to increase to what the bank believes will be a maximum achievable level of roughly 92 million bpd, it said.

Even if this record level is achievable, global demand growth at 1 per cent annually would still leave the market tight, it added.

There was considerable downside to much of the post-2013 production schedule, the report said, citing political wrangling over Project Kuwait, oil laws in Brazil, militant attacks in Nigeria and an array of issues with Iraq, Iran and Venezuela that will put global spare capacity at risk.

Lux Energy Corporation

Lux Energy is an oil and gas production and exploration company focusing on developing oil and gas resources in North America.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Lux Energy's filings with the Securities and Exchange Commission which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

LUX Energy Corporation

CONTACT: please visit http://www.luxenergycorp.com/ or contact Shane Broesky at:
Corporate Office, Suite 1950 - 777 8th Ave S.W., Calgary, Alberta, T2P 3R5,
Canada; Investor Relations Manager, TF: (866) 581-3484,
info@luxenergycorp.com

Stacy Kniffen Paquet to Speak at 2009 Risk Management and Finance Summit for Nonprofits

CANTON, Mass., Sept. 18 /PRNewswire/ -- OneBeacon Professional Insurance, a member of OneBeacon Insurance Group , today announced that Assistant Vice President and Management Liability Product Manager Stacy Kniffen Paquet will be a featured speaker at the 2009 Risk Management and Finance Summit for Nonprofits on September 20-22 at the University of Texas at Austin in Austin, Texas.

The Risk Management and Finance Summit, which is hosted by the Nonprofit Risk Management Center, is an annual educational event focusing on relevant topics and trends affecting the nonprofit sector. Kniffen Paquet, who also spoke at the conference last year, will lead a discussion on the Implications of Directors' and Officers' Fiduciary Failures in Nonprofit Organizations.

Said Kniffen Paquet, "In today's economy, it's important for nonprofit board members to understand the importance of D&O insurance and the value of securing the right coverage to match their organization's needs."

OneBeacon Professional Insurance is a member of OneBeacon Insurance Group that specializes in professional liability solutions for targeted industries including hospitals of all sizes, physician groups, managed care organizations, long-term care facilities, health care facilities, media organizations, real estate professionals and lawyers. Additionally, OneBeacon Professional Insurance provides employment practices liability insurance, management liability and tailored products for complex organizations including health care provider excess insurance and HMO reinsurance.

About OneBeacon: OneBeacon Insurance Group's underwriting companies offer a range of specialty and segmented commercial and personal insurance products sold through select independent agents, regional and national brokers, and wholesalers. As one of the oldest property and casualty insurers in the United States, OneBeacon traces its roots to 1831 and the Potomac Fire Insurance Company. Today, OneBeacon's specialty insurance businesses are national in scope, while commercial lines business is produced in select territories throughout the United States. Personal lines business is concentrated in the Northeastern United States.

OneBeacon's U.S. headquarters is in Canton, Massachusetts. The company is publicly traded on the New York Stock Exchange under the symbol "OB".

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts, included or referenced in this release which address activities, events or developments which we expect or anticipate will or may occur in the future are forward-looking statements. The words "will," "believe," "intend," "expect," "anticipate," "project," "estimate," "predict" and similar expressions are also intended to identify forward-looking statements. These forward-looking statements include, among others, statements with respect to OneBeacon's:

-- change in book value per share or return on equity; -- business strategy; -- financial and operating targets or plans; -- incurred loss and loss adjustment expenses and the adequacy of its loss and loss adjustment expense reserves and related reinsurance; -- projections of revenues, income (or loss), earnings (or loss) per share, dividends, market share or other financial forecasts; -- expansion and growth of our business and operations; and -- future capital expenditures.

These statements are based on certain assumptions and analyses made by OneBeacon in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors believed to be appropriate in the circumstances. However, whether actual results and developments will conform to our expectations and predictions is subject to a number of risks and uncertainties that could cause actual results to differ materially from expectations, including:

-- claims arising from catastrophic events, such as hurricanes, windstorms, earthquakes, floods, fires, explosions, terrorist attacks or severe winter weather; -- recorded loss and loss adjustment expense reserves subsequently proving to have been inadequate; -- the continued availability and cost of reinsurance coverage; -- the continued availability of capital and financing; -- general economic, market or business conditions; -- business opportunities (or lack thereof) that may be presented to it and pursued; -- competitive forces, including the conduct of other property and casualty insurers and agents; -- changes in domestic or foreign laws or regulations, or their interpretation, applicable to OneBeacon, its competitors, its agents or its customers; -- an economic downturn or other economic conditions adversely affecting its financial position including stock market volatility; -- actions taken by ratings agencies from time to time, such as financial strength or credit ratings downgrades or placing ratings on negative watch; -- the risks that are described from time to time in OneBeacon's filings with the Securities and Exchange Commission, including but not limited to OneBeacon's Annual Report on the Form 10-K for the fiscal year ended December 31, 2008 filed February 27, 2009.

Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by OneBeacon will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, OneBeacon or its business or operations. OneBeacon assumes no obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or otherwise.

OneBeacon Insurance Group

CONTACT: Sasha Valasek, +1-781-332-7165, svalasek@onebeacon.com

Web Site: http://www.onebeacon.com/

Zions Bancorporation Announces Pricing of $450 Million 7.75% Senior Notes Due 2014

SALT LAKE CITY, Sept. 18 /PRNewswire-FirstCall/ -- Zions Bancorporation ("Zions" or the "Company") announced today that it successfully priced its offering of $450,000,000 fixed-rate senior unsecured notes to mature in 2014 with a coupon of 7.75% (the "Notes") in an underwritten public transaction (an increase in principal amount from what was originally anticipated). The Notes were sold at a price of 86.888. The completion of this offering further augments the Company's liquidity position in what remains an uncertain economic environment. Deutsche Bank Securities and Goldman, Sachs & Co. served as the lead joint book running managers and Banc of America Securities LLC, J.P. Morgan Securities Inc. and Zions Direct, Inc. served as co-joint book running managers for the offering.

An automatic shelf registration statement on Form S-3 relating to this offering was filed with the Securities and Exchange Commission on March 31, 2009 and became effective upon filing. The final prospectus supplement relating to the offering will be filed with the Securities and Exchange Commission. Copies of the final prospectus supplement, when available, may be obtained for free by visiting EDGAR on the SEC Web site at http://www.sec.gov/. Alternatively, you may contact Deutsche Bank Securities, 60 Wall Street, New York, NY 10005, Attention: Investment Grade Debt Syndicate, 1-800-503-4611 or Goldman, Sachs & Co., 85 Broad Street, New York, New York 10004, Attention: Prospectus Department, 1-866-471-2526, or by e-mail at prospectus-ny@ny.email.gs.com.

This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy senior notes of the company or any other securities and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Zions Bancorporation is one of the nation's premier financial services companies, consisting of a collection of great banks in select high growth markets. Zions operates its banking businesses under local management teams and community identities through approximately 500 offices in 10 Western and Southwestern states: Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah and Washington. The company is a national leader in Small Business Administration lending and public finance advisory services. In addition, Zions is included in the S&P 500 and NASDAQ Financial 100 indices.

Forward-Looking Information

This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations or forecasts of future events. These forward-looking statements are not guarantees of future performance, nor should they be relied upon as representing management's views as of any subsequent date. Forward-looking statements, including those contained herein regarding the underwritten public offering of senior unsecured notes, involve significant risks and uncertainties and actual results may differ materially from those presented, either expressed or implied, in this news release. Factors that might cause such differences include, but are not limited to: the Company's ability to successfully execute its business plans and achieve its objectives; changes in general economic and financial market conditions, either internationally, nationally or locally in areas in which the Company conducts its operations, including changes in securities markets and valuations in structured securities and other assets; changes in governmental policies and programs resulting from general economic and financial market conditions; changes in interest and funding rates; continuing consolidation in the financial services industry; new litigation or changes in existing litigation; increased competitive challenges and expanding product and pricing pressures among financial institutions; legislation or regulatory changes which adversely affect the Company's operations or business; and changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other regulatory agencies.

Additional factors that could cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the 2008 Annual Report on Form 10-K and the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2009 and June 30, 2009 of the Company filed with the Commission and available at the Commission's Internet site (http://www.sec.gov/).

The Company specifically disclaims any obligation to update any factors or to publicly announce the result of revisions to any of the forward-looking statements included herein to reflect future events or developments.

Zions Bancorporation

CONTACT: James Abbott, Director of Investor Relations and External
Communications of Zions Bancorporation, +1-801-844-7637

Web Site: http://www.zionsbancorporation.com/

Catalyst proposes Elk Falls mill restart plan to union locals

RICHMOND, BC, Sept. 18 /PRNewswire-FirstCall/ -- Catalyst Paper (TSX:CTL) today presented the two union locals representing workers at the Elk Falls paper mill with a plan that would result in the restart of production. The company's plan provides for the start up of at least two of the mill's paper machines and a profit sharing system based on the company's earnings, in return for changes to wages and benefits. Under the company's plan, the average hourly wage rate would remain in excess of $26.00.

"Our business is in the grip of a deep cyclical downturn, coupled with demand shifts and structural changes. We have to make adjustments to the cost structure of each of our mills to give them the greatest opportunity for a successful operation long-term," said Richard Garneau, president and chief executive officer.

"We would rather work through the details of the issues facing the Elk Falls mill together with the union locals, but they declined that opportunity and asked the company for a plan," he said. "We recognize our plan proposes changes to the status quo at the mill but believe it reflects the need to adapt to the lower-cost demands of our new, smaller, highly competitive market," he added.

The Elk Falls mill was indefinitely idled in early February with resulting layoffs affecting approximately 400 hourly and staff employees. Elk Falls hourly employees are represented by Communications, Energy and Paperworkers Union of Canada (CEP) locals 630 and 1123.

Catalyst Paper manufactures diverse specialty printing papers, newsprint and pulp. Its customers include retailers, publishers and commercial printers in North America, Latin America, the Pacific Rim and Europe. With six mills strategically located in British Columbia and Arizona, Catalyst has a combined annual production capacity of 2.5 million tonnes. The company is headquartered in Richmond, British Columbia, Canada and its common shares trade on the Toronto Stock Exchange under the symbol CTL. Catalyst is listed on the Jantzi Social Index(R) and is also ranked by Corporate Knights as one of the 50 Best Corporate Citizens in Canada.

Catalyst Paper Corporation

CONTACT: Lyn Brown, Vice President, Corporate Relations, (604) 247-4713

Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference

SAN DIEGO, Sept. 18, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the UBS Global Life Sciences Conference on September 23, 2009 at 3:30 p.m. Eastern Time (12:30 p.m. Pacific Time) at the Grand Hyatt Hotel in New York City. Jack Lief, Arena's President and Chief Executive Officer, is scheduled to provide an overview of the company, including its clinical development and discovery programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com/. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena has a broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, which includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals and Arena are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the timing, success and cost of Arena's lorcaserin program and other of its research and development programs; results of clinical trials or preclinical studies may not be predictive of future results; clinical trials and studies may not proceed at the time or in the manner Arena expects or at all; Arena's ability to partner or commercialize lorcaserin or other of its compounds or programs; the timing and ability of Arena to receive regulatory approval for its drug candidates; Arena's ability to obtain additional funds; Arena's ability to obtain and defend its patents; and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Contact: Arena Pharmaceuticals, Inc. Jack Lief President and Chief Executive Officer Cindy McGee Manager, Investor Relations and Corporate Communications 858.453.7200, ext. 1479 Media Contact: Russo Partners David Schull, President david.schull@russopartnersllc.com 212.845.4271

Arena Pharmaceuticals, Inc.

CONTACT: Jack Lief, President and Chief Executive Officer, or Cindy
McGee, Manager, Investor Relations and Corporate Communications,
+1-858-453-7200, ext. 1479, both of Arena Pharmaceuticals, Inc., Media, David
Schull, President of Russo Partners, +1-212-845-4271,
david.schull@russopartnersllc.com, for Arena Pharmaceuticals, Inc.

Web Site: http://www.arenapharm.com/

Nektar Therapeutics to Present at the UBS 2009 Global Life Sciences Conference in New York City

SAN CARLOS, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Nektar Therapeutics is scheduled to present at the upcoming UBS 2009 Global Life Sciences Conference in New York at the Grand Hyatt Hotel on Tuesday, September 22, 2009 at 10:30 a.m. Eastern time.

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com/. This Webcast will be available for replay until October 25, 2009.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar's technology and drug development expertise have enabled nine approved products in the U.S. or Europe for partners, which include leading biopharmaceutical companies, including UCB's Cimzia , Roche's PEGASYS for hepatitis C and Amgen's Neulasta for neutropenia. Nektar has created a robust pipeline of potentially high-value therapeutics to address unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. Nektar is currently conducting clinical and preclinical programs in oncology, pain and other therapeutic areas. NKTR-102, PEGylated irinotecan, is currently in Phase 2 clinical studies in ovarian, breast and colorectal cancer. NKTR-105, PEGylated docetaxel, is currently in a Phase 1 clinical study in patients with refractory solid tumors.

Nektar is headquartered in San Carlos, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com/.

Nektar Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 jruddock@nektar.com Susan Noonan The SAN Group 212-966-3650 susan@sanoonan.com

Nektar Therapeutics

CONTACT: Jennifer Ruddock of Nektar Therapeutics, +1-650-631-4954,
jruddock@nektar.com; or Susan Noonan of The SAN Group, +1-212-966-3650,
susan@sanoonan.com, for Nektar Therapeutics

Web Site: http://www.nektar.com/

Aptilon Announces Acquisition of Direct Medical Data, LLC and BLM Incorporated and Concurrent Private Placements

MONTREAL, Sept. 18 /PRNewswire-FirstCall/ -- Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").

"DMD's healthcare provider marketing services complement and expand our existing access to physicians," said Dr. Roger Korman, Chairman and CEO of Aptilon. "DMD's comprehensive healthcare provider database resources, especially its email database, are vital assets that will support the expansion of our online physician network. Aptilon has already distinguished itself as a company that successfully reaches and engages physicians in learning activities on behalf of pharmaceutical companies. Our existing customer relationships will open new sales channels for DMD services, which will be incorporated into our AxceIRx platform that continues to be adopted by pharmaceutical companies. In this way the acquisition combines the strengths of Aptilon and DMD to uniquely address the internet-based marketing needs of physicians and pharmaceutical providers."

DMD develops, markets and sells software applications that extract the value from healthcare provider databases which are licensed, sourced, or owned by DMD. DMD is a healthcare information company that provides comprehensive, accurate, and up-to-date medical and healthcare provider data. DMD has access to over 60 databases through licenses, strategic partnership or supplier relationships, representing the entire universe of medical/healthcare providers. DMD is a licensee of the American Medical Association (AMA) database. DMD assets include a permission-based email database that DMD has assembled of more than 500,000 unique healthcare practitioners. DMD's service offering is based on its enterprise-class, SQL relational database which enables DMD to create data-driven extracts that power client initiatives.

The purchase of the Purchased Assets has been made through DMD Marketing LP, a Delaware limited partnership (the "New LP"), and its wholly-owned subsidiary DMD Marketing Corp., a Delaware corporation ("Newco"), which are both indirect affiliates of Aptilon. The Purchased Assets include office equipment, accounts receivables, rights under various contracts, licenses and leases, intellectual property, books, records, files and other data and assets.

The total consideration for the Purchased Assets is estimated at US $31,677,072, subject to adjustment based on the net working capital as of the Closing Date, comprised of US $2,000,000 in cash, US $27,200,000 by way of non-convertible, non-interest bearing promissory note repayable on a monthly basis over a period of three years with a lump sum payment of approximately US $12,417,000 on the third anniversary of the Closing (or four years with a lump sum payment of approximately US $7,417,000 on the fourth anniversary of the Closing if New LP and Newco exercise an extension right), and approximately US $1,643,738 by the issuance of 15,000,000 common shares of Aptilon at approximately CDN $0.11163 per share. In addition, the purchasers assume various liabilities and obligations of the sellers including the assumption of a debt in the amount of approximately US $833,333 and the accounts payable of DMD.

The common shares of Aptilon issued pursuant to this acquisition are subject to a four-month hold period, in accordance with applicable securities legislation and policies of the TSX Venture Exchange. The parties have agreed that certificates representing 7,500,000 of the 15,000,000 common shares of Aptilon will be put in escrow with an escrow agent for a period of one year. The escrow agreement provides for an early release of the shares in various circumstances including a take-over bid, an arrangement or a merger.

In their audited combined statement of Income for the year ended December 31, 2008, DMD and BLM reported $9.2 million in revenue and $549,000 in net income. The audited combined balance sheet of DMD and BLM as at December 31, 2008 reported current assets of $3.2 million, total assets of $5.9 million, current liabilities of $2.0 million and total liabilities of $2.8 million.

For the six-month period ended June 30, 2009, non-audited results of operations showed revenue of $4.3 million and net income of $305,000, $2.6 million in current assets, total assets of $5.3 million, current liabilities of $1.2 million and total liabilities of $2.0 million.

Subject to adjustments further to the transaction, pro-forma income statements indicates the EBITDA would be in excess of $4.0 million on an annual basis at the current level of revenue.

This transaction is entirely at arm's length. No finder's fee is payable. Blackmont Inc. has acted as an advisor for the transaction.

Concurrent Private Placements -----------------------------

In connection with the purchase of the Purchased Assets, Aptilon has proceeded with a concurrent private placement of 4,545,455 common shares for an aggregate amount of CDN $500,000 to SIPAR Inc., an investor dealing at arm's length. SIPAR Inc. has also purchased a non convertible debenture in the amount of CDN $1,000,000, bearing interest at 16% per annum and repayable in biyearly (twice a year) installments over a period of three years.

The Corporation also issued to another investor dealing at arm's length a non convertible debenture in the amount of US $500,000 and bearing interest at 12.5% per annum repayable on the third anniversary of its issuance. As consideration for the subscription of the debenture by the investor the Corporation has issued to it 2,300,000 warrants entitling to holder to subscribe to common shares of the Corporation at the price of CDN $0.25 per share until the third anniversary of their issuance.

The proceeds of these private placements will be used to fund the cash portion of the purchase price of the Purchased Assets. The private placements and the issuance of bonus warrants are subject to final approval of the TSX Venture Exchange.

The securities issued under the private placements will be subject to a four month hold period, in accordance with applicable securities legislation and policies of the TSX Venture Exchange.

About Aptilon Corporation -------------------------

Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with physicians via the Internet through its innovative AxcelRx(SM) Live video detailing (with company reps), virtual programs, peer selling and other sales and marketing programs. Leading health care companies have adopted Aptilon's ReachNet(SM) Physician Access Channel, driving tens of thousands of high-quality rep-physician interactions averaging eight to ten minutes in length. Aptilon provides the infrastructure necessary for sales representatives to build physician awareness, understanding and preference during ail stages of a product's life cycle, from pre-launch education through end stage support. For more information, visit http://www.aptilon.com/.

AxcelRx(SM) and ReachNet(SM) are service marks of Aptilon Corporation. Forward-Looking Statements --------------------------

This news release contains forward-looking information. These statements relate to future events or future performance and reflect managements current expectations and assumptions. Such forward-looking statements reflect managements current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

APTILON CORPORATION

CONTACT: Denis Martineau, President, Aptilon Corporation,
1-888-544-8866, investors@aptilon.com; Ross Marshall, Investor Relations, The
Equicom Group, (416) 815-0700 ext. 238, rmarshall@equicomgroup.com; For U.S.
Media: Mark Gleason, Aptilon Corporation, (847) 331-8628,
mgleason@aptilon.com; For Canadian Media: Coriena Riendeau, Aptilon
Corporation, 1-888-544-8866, criendeau@aptilon.com

Delta TechOps to be Provider for LAN Airlines Boeing 767 Winglet Installations

ATLANTA, Sept. 18 /PRNewswire-FirstCall/ -- Delta Air Lines' maintenance division, Delta TechOps, today announced it has penned a one-year contract with Latin American leading airline, LAN Airlines to install winglets and provide airframe maintenance services on some of LAN's Boeing 767 fleet.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090317/CL84666LOGO )

Winglets, which are wing-tip extensions designed to reduce aircraft drag and alter airflow, will help LAN with fuel efficiency. Underscoring LAN's commitment to the environment, the winglets will reduce the airline's fuel usage by approximately 450,000 tons per year and decrease CO2 emissions for each aircraft by five percent.

"We are the world's largest operator of Boeing 767s, so it stands to reason that our technicians have a great deal of knowledge and expertise with this fleet," said Tony Charaf, president of Delta TechOps. "This partnership helps further establish Delta TechOps as an industry leader for Boeing 767 winglet installations."

"We are incorporating the most modern technology available in the industry to create the most efficient operational systems that significantly contribute to the preservation of the environment," said Enrique Elsaca, LAN Airlines senior vice president of Operations. "For LAN, the winglet program is a key initiative, and we are confident that Delta will provide an outstanding result and achieve the committed timeframes."

About LAN

LAN Airlines is one of the leading passenger and cargo airlines in Latin America. The company and its affiliates serve over 65 destinations around the world through an extensive network that offers full connectivity within Latin America, while also linking the region with North America, Europe and the South Pacific, as well as 63 additional international destinations through its various alliances. LAN Airlines and its affiliates have a leading position in their respective domestic markets of Chile and Peru, an important presence in the Argentinean domestic market and recently begun domestic operations in Ecuador.

Currently, LAN Airlines and its affiliates operate one of the most modern fleets in the world, with 84 passenger aircraft, and its cargo subsidiary, LAN CARGO and its respective cargo affiliates, have a fleet of 11 freighters. The company recently completed its short haul fleet renovation process by acquiring new aircraft from the Airbus A320 family, enabling LAN to improve its efficiency and to reduce significantly its CO2 emissions. The fleet renovation is part of the company's commitment to the protection of the environment.

LAN is one of the few Investment Grade airlines in the world (BBB). The company's world class quality standards enabled its membership in oneworld(TM), the global alliance that encompasses the best airlines in the world. For more information please visit http://www.lan.com/ or http://www.oneworldalliance.com/.

About Delta TechOps

Delta TechOps is the largest airline maintenance, repair and overhaul in North America, generating more than $500 million in revenue in 2008. In addition to providing maintenance and engineering support for Delta's fleet of more than 750 aircraft, Delta TechOps serves more than 150 other aviation and airline customers around the world, specializing in high-skill work like engines, components, hangar and line maintenance. Delta TechOps employs more than 8,500 maintenance professionals and is one of the world's most experienced providers with more than seven decades of aviation expertise. More about Delta TechOps is available at deltatechops.com.

Photo: http://www.newscom.com/cgi-bin/prnh/20090317/CL84666LOGO Delta Air Lines

CONTACT: Delta Corporate Communications, +1-404-715-2554

Web Site: http://www.deltatechops.com/

KeyCorp Third Quarter 2009 Earnings Release Date and Conference Call

CLEVELAND, Sept. 18 /PRNewswire-FirstCall/ -- KeyCorp will announce third quarter 2009 earnings on Wednesday, October 21, 2009. A conference call will be held at 9:00 a.m. ET to review financial results. The call may also include forward looking information on financial trends, asset quality and earnings outlook.

A live audio webcast of the conference call, as well as the earnings release and presentation materials will be available prior to the call at https://www.key.com/ir . If you are unable to join the live conference call, or wish to hear a re-broadcast, access https://www.key.com/ir and select Presentations.

For more information contact: Media: Bill Murschel, 216.828.7416, william_c_murschel@keybank.com Investor Relations: Vern Patterson, 216.689.0520, vernon_patterson@keybank.com Investor Relations: Chris Sikora, 216.689.3133, chris_sikora@keybank.com

Cleveland-based KeyCorp is one of the nation's largest bank-based financial services companies, with assets of approximately $98 billion. BusinessWeek Magazine named Key the top bank in its Customer Service Champ 2009 edition, ranking Key 11th out of the top-25 companies that include many known for their customer service acumen. Key companies provide investment management, retail and commercial banking, consumer finance, and investment banking products and services to individuals and companies throughout the United States and, for certain businesses, internationally. For more information, visit https://www.key.com/.

KeyCorp

CONTACT: Media: William C. Murschel, +1-216-828-7416,
william_c_murschel@keybank.com; or Analysts: Vernon L. Patterson,
+1-216-689-0520, vernon_patterson@keybank.com, or Christopher F. Sikora,
+1-216-689-3133, chris_sikora@keybank.com

Web Site: https://www.key.com/

Hayes Lemmerz International, Inc. Realigns Global Operations

NORTHVILLE, Mich., Sept. 18 /PRNewswire-FirstCall/ -- Hayes Lemmerz International, Inc. ("Hayes" or the "Company") announced today that effective September 1, 2009, the Company realigned its global operational sites into three regions.

The organization will be aligned into three regions. The first region is Turkey.

The second region is Europe, Africa and Asia Pacific (EAAP).

Pieter Klinkers - Vice President Sales & Marketing has been promoted to President - Europe, Africa & Asia Pacific.

David Kasul - Managing Director - Brazil has been promoted to Vice President - Operations for Europe and Africa.

Marc Hendrickx will replace Klinkers in the role of Vice President - Sales & Marketing.

The third region is "The Americas" which consists of North America, Mexico and Brazil.

Donald Hampton - Vice President - North American Wheels Group has been promoted to Vice President and General Manager for the Americas.

Luis Blecher - Financial Director - Brazil has been promoted to Managing Director of Brazil to replace David Kasul and will be responsible for all Brazilian operations.

About Hayes Lemmerz International, Inc.

Hayes Lemmerz International, Inc.

CONTACT: Eric Moraw, Hayes Lemmerz International, +1-734-737-5679

Web Site: http://www.hayes-lemmerz.com/

AXA Equitable Announces Four Senior Vice President Appointments

NEW YORK, Sept. 18 /PRNewswire-FirstCall/ -- AXA Equitable Life Insurance Company announced today that Leann Bohner, Josh Braverman, Michael Healy and Jeffrey Turcotte have been elected to the position of senior vice president. The appointments were confirmed during a Board of Directors meeting held yesterday afternoon.

"Integral to our success is the foundation of a strong leadership team," said Christopher M. "Kip" Condron, chairman and chief executive officer of AXA Equitable. "Leann, Josh, Michael and Jeffrey are clearly significant parts of that foundation, and we congratulate them on their respective appointments."

Leann Bohner is a senior information officer for AXA Equitable's Information Technology area. Ms. Bohner joined the company in 2006, and she currently leads the Enterprise Annuity Systems department where she is responsible for managing all annuity systems and support. She reports to Kevin Murray, executive vice president and chief information officer.

Josh Braverman recently joined AXA Equitable as head of derivatives. In this role, Mr. Braverman leads the Dynamic Hedging team and is responsible for developing and implementing the company's derivatives and hedging strategies. He reports to Richard Dziadzio, executive vice president and chief financial officer.

Prior to joining the company, Mr. Braverman was global head of derivatives for AEGON. He has also worked for the U.S. Treasury Department, Deutsche Bank and Goldman Sachs.

Michael Healy is an operations officer for AXA Equitable's Information Technology area, also reporting to Mr. Murray. Mr. Healy joined the company in 2006, and in his current role he manages and directs information technology operations that include strategy, financial management, vendor management, process improvement, business analysis, quality assurance and project management.

Mr. Healy is also responsible for managing the information technology operations that support learning and development, business continuity, Sarbanes Oxley and audit.

Jeffrey Turcotte is senior actuary, reporting to Charles Marino, executive vice president and chief actuary for AXA Equitable. In his current role, Mr. Turcotte oversees the valuation side of the company's hedge program valuations and develops AXA Equitable's hedge strategies to adapt to changing markets.

Mr. Turcotte joined the company in 1991 as an actuarial associate. He has international AXA experience, having worked with AXA Equity and Law, based in the United Kingdom.

About AXA Equitable

In business since 1859, AXA Equitable Life Insurance Company is a leading financial protection company and one of the nation's premier providers of life insurance and annuity products, as well as investment products and services through a subsidiary, AXA Advisors, LLC. The company's products and services are distributed to individuals and business owners through its retail distribution channel, AXA Advisors; to the financial services market through its wholesale distribution channel, AXA Distributors, LLC; and to corporations and their employees through its corporate distribution channel, Corporate Markets.

AXA Equitable, a subsidiary of AXA Financial Inc., is part of the global AXA Group, a worldwide leader in financial protection strategies and wealth management. "AXA Group" refers to AXA, a French holding company for an international group of insurance and financial services companies together with its direct and indirect consolidated subsidiaries. For more information, visit http://www.axa-equitable.com/.

AXA Equitable Life Insurance Company

CONTACT: Michael Arcaro, +1-212-314-2030,
michael.arcaro@axa-equitable.com, or Jo Ann Tizzano, +1-212-314-2979,
joann.m.tizzano@axa-equitable.com, both of AXA Equitable

Web Site: http://www.axa-equitable.com/

Advantest Targets New Markets with Terahertz Wave Measurement Technology. . .Successfully Develops World's First Terahertz Wave 3D Imaging System

TOKYO, Sept. 18 /PRNewswire-FirstCall/ -- Advantest Corporation today announced that it has successfully developed the world's first terahertz wave imaging system, using Advantest's original terahertz wave technology, for nondestructive three dimensional (3D) analysis and inspection. The system is the first product developed within the framework of Advantest's New Concept Product Initiative, launched in March 2009, and is expected to form a cornerstone of the company's new business strategy. Anticipating diverse industrial applications for terahertz waves, Advantest has announced a commitment to exploring applications in fields including industrial materials, medicine, biotechnology and security.

Straddling the border between radio and optical emissions, terahertz waves have frequencies ranging from a few tens GHz to 100 THz. These electromagnetic waves possess remarkable properties including absorption spectra (also known as fingerprint spectra) that enable them to penetrate visually opaque materials. In addition, their spatial resolution is suitable for practical spectroscopic imaging applications. However, basic techniques for THz generation, detection, and measurement, until recently, had not been developed for commercial use, hampering the exploration of practical applications for terahertz wave technology.

Advantest has now announced the successful development of its Terahertz Wave 3D Imaging System, which integrates the company's longstanding expertise in optical and electronic measurement with its newly developed, proprietary femtosecond fiber laser technology, as well as imaging technology developed by Advantest in collaboration with Dr. Kodo Kawase of Nagoya University. The system boasts unprecedented capabilities for nondestructive visual analysis of the spatial distribution, chemical identification, and quantification of constituents of the material under inspection, e.g. ceramics or plastics.

Further, the new system's high-speed reflection-transmission measurement function, covering the 0.02-3 THz band (up to 7 THz in the optional configuration), allows probing for specific substances within a sample under inspection and providing 3D images, facilitating analysis of the spatial distribution of constituents or structural defects within the sample. In industrial applications, terahertz wave imaging enables a level of analysis that is impossible with microwave, infrared, X-ray, or ultrasonic techniques. And in the even more complex realms of medicine and biotechnology, potential applications for terahertz wave imaging include crystal polymorphism and ingredient analysis. Advantest is in the process of developing chemical and industrial applications for the new system, and is engaged in continuing research, in partnership with customers, to further expand the scope of new applications.

Advantest will exhibit the Terahertz Wave 3D Imaging System at Electrotest Japan, to be held Jan. 20 - 22 at Tokyo Big Sight, Japan.

- System Overview

The Terahertz Wave 3D Imaging System integrates ultra-short pulse femtosecond fiber laser technology, high-speed measurement technology employing terahertz wave radiation, terahertz wave sensor technology for improved sensitivity, and 3D tomographic imaging technology to enable nondestructive 3D analysis of samples. In addition, it exploits the properties of terahertz waves, including their substance-intrinsic absorption spectrum and transparency, to enable probing and analysis of specific constituents of samples.

(1) 3D Imaging Analysis Using Terahertz Waves

Using newly developed technology to compensate for refraction in the terahertz wave region, conducting a spatial scan of each sample while measuring its transmission characteristics, and taking advantage of computed tomography (CT) techniques for reconstructing images by means of the back projection method, Advantest's new system provides 3D images of measurement results, facilitating analysis of sample structure and constituent ingredients. The company has also developed a terahertz wave high-speed optical sampling technique that uses Advantest's proprietary ultra-short pulse femtosecond fiber laser technology for high-accurate sampling timing, delivering measurement throughput approximately 1000 times greater than the company's previous system, and allowing the new system to obtain its 3D images with unprecedented rapidity.

(2) Broadband Terahertz Wave Spectroscopic Measurement

Advantest's original ultra-short pulse femtosecond fiber laser supplies pulses of 80 fs duration with a highly stable repetition rate, enabling spectroscopic analysis at frequencies up to 3 THz, with an optional configuration covering the frequencies up to 7 THz. This enables broadband analysis of the fingerprint spectra of industrial, chemical, and bio-related materials.

(3) Parallel Measurement Capability for Volume Production Inspection

In combination with its high-speed measurement throughput, additional terahertz wave generation and detection modules may easily be mounted in the system to provide as many as 20 channels, enabling the system to carry out terahertz wave inspection on volume production lines. Additionally, the generation and detection modules may be flexibly positioned to accommodate the shape and location of various measurement targets. The system is customizable to customer requirements and individual measurement locations.

For more information: Greg Self, g.self@advantest.com About Advantest

Advantest Corporation is the world's leading automatic test equipment supplier to the semiconductor industry, and also produces electronic instruments and systems. A global company, Advantest has long offered total ATE solutions, and serves the industry in every component of semiconductor test: tester, handler, mechanical and electrical interfaces, and software. Its logic, memory, mixed-signal and RF testers and device handlers are integrated into the most advanced semiconductor production lines in the world. Founded in Tokyo in 1954, Advantest established its first subsidiary in 1982, in the USA, and now has subsidiaries worldwide. Among them, Advantest America, Inc. is based in Santa Clara, CA., Advantest Europe GmbH is based in Munich, Germany, and Advantest Taiwan Inc. is based in Hsinchu, Taiwan. More information is available at http://www.advantest.com/

Advantest Corporation

CONTACT: Amy Gold, Advantest America, Inc., +1-212-850-6670,
a.gold@advantest.com

Web Site: http://www.advantest.com/

Continental Resources, Inc. Announces Pricing of $300 Million Offering of Senior Notes

ENID, Okla., Sept. 18 /PRNewswire-FirstCall/ -- Continental Resources, Inc. ("Continental" or the "Company") announced today the pricing of its private placement of $300 million of 8.25% senior unsecured notes due 2019. The notes were sold at 99.160% of par to yield 8.375% to maturity. The offering is expected to close on September 23, 2009, subject to customary closing conditions. Continental intends to use the net proceeds from the offering to repay a portion of the borrowings outstanding under its revolving credit facility.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080505/LAM014LOGO)

The securities offered have not been registered under the Securities Act of 1933, as amended, (the "Securities Act"), or any state securities laws; and unless so registered, the securities may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The senior unsecured notes are expected to be eligible for trading by qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.

This press release is being issued pursuant to Rule 135c under the Securities Act, and is neither an offer to sell nor a solicitation of an offer to buy the notes or any other securities and shall not constitute an offer to sell or a solicitation of an offer to buy, or a sale of, the notes or any other securities in any jurisdiction in which such offer, solicitation or sale is unlawful.

This press release includes forward-looking information that is subject to a number of risks and uncertainties, many of which are beyond the Company's control. All information, other than historical facts included in this press release, regarding strategy, future operations, drilling plans, estimated reserves, future production, estimated capital expenditures, projected costs, the potential of drilling prospects and other plans and objectives of management are forward-looking information. All forward-looking statements speak only as of the date of this press release. Although the Company believes that the plans, intentions and expectations reflected in or suggested by the forward-looking statements are reasonable, there is no assurance that these plans, intentions or expectations will be achieved. Actual results may differ materially from those anticipated due to many factors, including oil and natural gas prices, industry conditions, drilling results, uncertainties in estimating reserves, uncertainties in estimating future production from enhanced recovery operations, availability of drilling rigs and other services, availability of crude oil and natural gas transportation capacity, availability of capital resources and other factors listed in reports we have filed or may file with the Securities and Exchange Commission.

Contact: Investor Relations Warren Henry, VP Investor Relations (580) 548-5127 warrenhenry@contres.com Media Brian Engel, VP Public Affairs (580) 249-4731 brianengel@contres.com

Photo: http://www.newscom.com/cgi-bin/prnh/20080505/LAM014LOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com Continental Resources

CONTACT: Investor Relations, Warren Henry, VP Investor Relations,
+1-580-548-5127, warrenhenry@contres.com, or Media, Brian Engel, VP Public
Affairs, +1-580-249-4731, brianengel@contres.com, both of Continental
Resources

Web Site: http://www.contres.com/

VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ

SAN FRANCISCO, Sept. 18 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on September 15, 2009, it received a deficiency letter from the NASDAQ Stock Market stating that the Company is not in compliance with the minimum $1.00 per share bid price requirement for continued listing, as set forth in Listing Rule 5550(a)(2), and that the Company's securities are, therefore, subject to delisting from The NASDAQ Capital Market.

The Company has a period of 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price listing requirement. If at any time during this grace period the bid price of the Company's common stock closes at $1.00 per share or more for a minimum of ten consecutive business days, the Company will receive written notification of its compliance with the minimum bid price listing requirement. In the event the Company does not regain compliance prior to the expiration of the grace period, the Company will receive written notification that its securities are subject to delisting. In such event, the Company may appeal NASDAQ's determination to a NASDAQ Listing Qualifications Panel (the "Panel"), which request will stay the delisting of the Company's securities pending the Panel's decision. Additionally, the Company has had a hearing with the Panel regarding its failure to meet capitalization requirements for continued listing and is awaiting a decision from the Panel. There can be no assurance that the Company will regain compliance with the minimum bid price listing or capitalization requirements and maintain its NASDAQ listing.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. VIA's lead candidate, VIA-2291, targets a significant unmet medical need: reducing inflammation in plaque, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. In addition, VIA's pipeline of drug candidates includes other compounds to address other underlying causes of cardiovascular disease: high cholesterol, diabetes and inflammation. For more information, visit: http://www.viapharmaceuticals.com/.

Forward Looking Statements

This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

-- our ability to borrow additional amounts under the loan from Bay City Capital, which is subject to the discretion of Bay City Capital; -- our ability to obtain necessary financing in the near term, including amounts necessary to repay the loan from Bay City Capital by the October 31, 2009 maturity date (or earlier if certain repayment acceleration provisions are triggered); -- our ability to control our operating expenses; -- our ability to comply with covenants included in the loan from Bay City Capital; -- our ability to maintain the listing of our common stock on NASDAQ; -- our ability to timely recruit and enroll patients in any future clinical trials; -- our failure to obtain sufficient data from enrolled patients that can be used to evaluate VIA-2291, thereby impairing the validity or statistical significance of our clinical trials; -- our ability to successfully complete our clinical trials of VIA- 2291 on expected timetables and the outcomes of such clinical trials; -- complexities in designing and implementing cardiometabolic clinical trials using surrogate endpoints in Phase 1 and Phase 2 clinical trials which may differ from the ultimate endpoints required for registration of a candidate drug; -- the results of our clinical trials, including without limitation, with respect to the safety and efficacy of VIA-2291; -- if the results of the ACS and CEA studies, upon further review and analysis, are revised, interpreted differently by regulatory authorities or negated by later stage clinical trials; -- our ability to obtain necessary FDA approvals, including to initiate future clinical trials of VIA-2291; -- our ability to successfully commercialize VIA-2291; -- our ability to identify potential clinical candidates from the family of DGAT1 compounds licensed and move them into preclinical development; -- our ability to obtain and protect our intellectual property related to our product candidates; -- our potential for future growth and the development of our product pipeline, including the THR beta agonist candidate and the other compounds licensed from Roche; -- our ability to obtain strategic opportunities to partner and collaborate with large biotechnology or pharmaceutical companies to further develop VIA-2291; -- our ability to form and maintain collaborative relationships to develop and commercialize our product candidates; -- general economic and business conditions; and -- the other risks described under Item 1A "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008, as supplemented by the risks described under Item 1A "Risk Factors" in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2009 and June 30, 2009, each on file with the SEC.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and VIA undertakes no obligation to update publicly any of these statements in light of new information or future events.

VIA Pharmaceuticals, Inc.

CONTACT: James G. Stewart, Senior Vice President and Chief Financial
Officer of VIA Pharmaceuticals, Inc., +1-415-283-2204

Web Site: http://www.viapharmaceuticals.com/

BusinessWeek/Interbrand Release Annual Ranking of the 100 'Best Global Brands'Coca-Cola retains the No. 1 spot; Google, Amazon, and Zara continue strong growth

NEW YORK, Sept. 17 /PRNewswire/ -- Google, Amazon, and Zara are among this year's top gainers in BusinessWeek and Interbrand's annual ranking of the "Best Global Brands." UBS slipped dramatically down the list, falling 31 places to No. 72, losing 50% of its brand value. Coca-Cola remains the No. 1 brand for the ninth year in a row.

For the ninth consecutive year, BusinessWeek has teamed up with Interbrand, a leading brand consultancy, to publish the ranking of the top 100 global brands by brand value. Amazon, Pepsi, Audi, Panasonic, and Campbell's have all prospered during a challenging year for marketing executives. For the first time, the overall value of the top 100 brands has declined 4.6%, or US $55,472. Seven brands, however, fell right off the list. Among the biggest: Merrill Lynch, which ranked No. 34 last year, and AIG, previously No. 54, after both required emergency assistance from the U.S. government. ING, ranked No. 86 last year, also fell off the list after huge subprime losses. Not surprisingly, big banks and auto brands fared the worst, while food brands benefited as consumers began eating more at home.

The recession has presented brand stewards with the most severe test of their careers. Companies have had to adjust rapidly as consumers reexamine their purchases and rethink brand loyalties. Marketing executives are balancing the temptation to chase short-term gains with discounts and promotions against the risk of cheapening their brands over the long haul. Meanwhile, most have considerably smaller budgets with which to reach their customers.

BusinessWeek's "Best Global Brands" special report is featured in the September 28, 2009 issue, on newsstands Friday, September 18th. Expanded content, including full methodology, is available on BusinessWeek.com at http://www.businessweek.com/go/brand and on Interbrand.com at http://www.thebestglobalbrands.com/.

About BusinessWeek

BusinessWeek is a global source of essential business insight that inspires leaders to turn ideas into action. Through content, context, and collaboration, BusinessWeek moderates global conversations and moves business professionals forward. Founded in 1929 and published by the McGraw-Hill Companies, BusinessWeek magazine is the market leader, with more than 4.8 million readers each week in 140 countries. Local language editions include Chinese, Thai, and Bahasa Indonesian. Launched in 1994, BusinessWeek.com is the preeminent provider of daily, essential business news, information, and services to business decision-makers. Business Exchange (http://bx.businessweek.com/) is an innovative online offering that aims to better serve the evolving information needs of business professionals.

About Interbrand

Interbrand, the leading brand consultancy, combines the rigorous strategy and analysis of a management consulting practice with the entrepreneurial and creative spirit of branding and design. The company offers a comprehensive array of consulting services that guide clients in the creation, enhancement, maintenance and valuation of their most valuable asset -- their brands. Founded in 1974, Interbrand has offices in over 30 cities in more than 20 countries around the globe and clients from among the most respected businesses. For more information visit the world's only online exchange about branding, produced by Interbrand, at http://www.brandchannel.com/.

BusinessWeek/Interbrand's Annual Ranking of the Best Global Brands For 2009

2009 Brand Value Percent Change Country of Rank Company $MILLIONS (over 2008) Ownership 1 Coca-Cola 68,734 3% US 2 IBM 60,211 2% US 3 Microsoft 56,647 -4% US 4 GE 47,777 -10% US 5 Nokia 34,864 -3% Finland 6 McDonald's 32,275 4% US 7 Google 31,980 25% US 8 Toyota 31,330 -8% Japan 9 Intel 30,636 -2% US 10 Disney 28,447 -3% US 11 Hewlett-Packard 24,096 2% US 12 Mercedes-Benz 23,867 -7% Germany 13 Gillette 22,841 4% US 14 Cisco 22,030 3% US 15 BMW 21,671 -7% Germany 16 Louis Vuitton 21,120 -2% France 17 Marlboro 19,010 -11% US 18 Honda 17,803 -7% Japan 19 Samsung 17,518 -1% S. Korea 20 Apple 15,443 12% US 21 H&M 15,375 11% Sweden 22 American Express 14,971 -32% US 23 Pepsi 13,706 3% US 24 Oracle 13,699 -1% US 25 Nescafe 13,317 2% Switzerland 26 Nike 13,179 4% US 27 SAP 12,106 -1% Germany 28 Ikea 12,004 10% Sweden 29 Sony 11,953 -12% Japan 30 Budweiser 11,833 3% US 31 UPS 11,594 -8% US 32 HSBC 10,510 -20% Britain 33 Canon 10,441 -4% Japan 34 Kellogg's 10,428 7% US 35 Dell 10,291 -12% US 36 Citi 10,254 -49% US 37 J.P. Morgan 9,550 -11% US 38 Goldman Sachs 9,248 -10% US 39 Nintendo 9,210 5% Japan 40 Thomson Reuters 8,434 1% Canada 41 Gucci 8,182 -1% Italy 42 Philips 8,121 -2% Netherlands 43 Amazon 7,858 22% US 44 L'Oreal 7,748 3% France 45 Accenture 7,710 -3% US 46 eBay 7,350 -8% US 47 Siemens 7,308 -8% Germany 48 Heinz 7,244 9% US 49 Ford 7,005 -11% US 50 Zara 6,789 14% Spain 51 Wrigley 6,731 10% US 52 Colgate 6,550 2% US 53 AXA 6,525 -7% France 54 MTV 6,523 -9% US 55 Volkswagen 6,484 -8% Germany 56 Xerox 6,431 1% US 57 Morgan Stanley 6,399 -26% US 58 Nestle 6,319 13% Switzerland 59 Chanel 6,040 -5% France 60 Danone 5,960 10% France 61 KFC 5,722 3% US 62 Adidas 5,397 6% Germany 63 Blackberry 5,138 7% Canada 64 Yahoo! 5,111 -7% US 65 Audi 5,010 -7% Germany 66 Caterpillar 5,004 -5% US 67 Avon 4,917 -7% US 68 Rolex 4,609 -7% Switzerland 69 Hyundai 4,604 -5% S. Korea 70 Hermes 4,598 1% France 71 Kleenex 4,404 -5% US 72 UBS 4,370 -50% Switzerland 73 Harley-Davidson 4,337 -43% US 74 Porsche 4,234 -8% Germany 75 Panasonic 4,225 -1% Japan 76 Tiffany & Co. 4,000 -5% US 77 Cartier 3,968 -6% France 78 Gap 3,922 -10% US 79 Pizza Hut 3,876 -5% US 80 Johnson&Johnson 3,847 7% US 81 Allianz 3,831 -5% Germany 82 Moet & Chandon 3,754 -5% France 83 BP 3,716 -5% Britain 84 Smirnoff 3,698 3% Britain 85 Duracell 3,563 -3% US 86 Nivea 3,557 5% Germany 87 Prada 3,530 -2% Italy 88 Ferrari 3,527 0% Italy 89 Armani 3,303 -6% Italy 90 Starbucks 3,263 -16% US 91 Lancome 3,235 N/A France 92 Shell 3,228 -7% Netherlands 93 Burger King 3,223 N/A US 94 Visa 3,170 -5% US 95 Adobe 3,161 N/A US 96 Lexus 3,158 -12% Japan 97 Puma 3,154 N/A Germany 98 Burberry 3,095 N/A Britain 99 PoloRalphLauren 3,094 N/A US 100 Campbell's 3,081 N/A US

BusinessWeek

CONTACT: BusinessWeek, Patti Straus, +1-212-512-2680, or Heather
Carpenter, +1-212-512-2854; or Interbrand, Lisa Marsala, +1-212-798-7646

Web Site: http://www.businessweek.com/

The Gymboree Corporation to Present at Bank of America Merrill Lynch Conference

SAN FRANCISCO, Sept. 18 /PRNewswire-FirstCall/ -- The Gymboree Corporation announced that Blair Lambert, CFO/COO and Jeff Harris, VP of Finance, will present at the Bank of America Merrill Lynch Conference, which will be held at the InterContinental Hotel in Boston on Tuesday, September 22, 2009, at 8:50 a.m. ET.

To listen to a live broadcast of The Gymboree Corporation's presentation over the Internet, please log on to http://www.gymboree.com/, click on "Our Company" at the bottom of the page, go to "Investor and Media Relations" and then "Conference Calls & Webcasts." The webcast will be archived three hours after the live event and will be available for 14 days, through October 6, 2009.

About The Gymboree Corporation

The Gymboree Corporation's specialty retail brands offer unique, high-quality products delivered with personalized customer service. As of August 29, 2009, the Company operated a total of 937 retail stores: 627 Gymboree stores (593 in the United States, 2 in Puerto Rico and 32 in Canada), 136 Gymboree Outlet stores, 120 Janie and Jack shops and 54 Crazy 8 stores in the United States.

The Company also operates online stores at http://www.gymboree.com/, http://www.janieandjack.com/ and http://www.crazy8.com/, and offers directed parent-child developmental play programs at 616 franchised and Company-operated Gymboree Play & Music centers in the United States and 30 other countries.

The Gymboree Corporation

CONTACT: Investor Relations, Jeffrey P. Harris, +1-415-278-7933,
investor_relations@gymboree.com, or Media Relations, Mark Mizicko,
+1-415-278-7503, media_relations@gymboree.com, both of The Gymboree
Corporation

Web Site: http://www.gymboree.com/

Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments

GUATEMALA CITY, Sept. 18 /PRNewswire-FirstCall/ -- Cancer patients in Guatemala and across Central America now have access to advanced radiotherapy treatments, including intensity-modulated radiotherapy (IMRT) with RapidArc technology. Hope International Centro de Radioterapia has become the first treatment center in Latin America to install the fast new treatment capability from Varian Medical Systems .

With RapidArc, Hope International Centro de Radioterapia, a new privately-funded clinic, can provide more advanced care to a greater number of patients than would be possible with conventional technology. It is equipped with state-of-the-art technology for delivering the full spectrum of image-guided cancer treatments.

"We are able to offer IMRT, which targets cancer cells while minimizing damage to surrounding tissues and organs," says Luis A. Linares, MD, Medical Director. "With RapidArc, we have the potential to further enhance our precision by completing many of these treatments more quickly, which can reduce the extent of patient motion during treatment. All treatments will be delivered using a high resolution multileaf collimator to shape the treatment beam so that it matches the shape and size of the tumor from every angle."

The new treatment technology was unveiled on September 10, 2009, at an inauguration attended by many local dignitaries, including Alvaro Arzu, mayor of Guatemala City; cabinet-level government officials; medical specialists from across the region; and prominent leaders from the private sector.

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided IMRT two to eight times faster than is possible with conventional IMRT.

"This is an important facility for this part of Central America," said James Miles, Varian's director of operations for Latin American and the Caribbean. "We commend Dr. Linares and his team for taking the initiative to provide state-of-the-art cancer care for the people of Guatemala and surrounding region."

Photo available. (Left to right: Dr. Luis A. Linares and Alvaro Arzu, mayor of Guatemala City, with the RapidArc-enabled linear accelerator during the unveiling ceremony on September 10, 2009).

ABOUT VARIAN MEDICAL SYSTEMS

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 79 sales and support offices around the world. For more information, visit http://www.varian.com/.

FOR INFORMATION CONTACT: Meryl Ginsberg, Varian Medical Systems 650-424-6444 or meryl.ginsberg@varian.com

Varian Medical Systems, Inc.

CONTACT: Meryl Ginsberg of Varian Medical Systems, +1-650-424-6444,
meryl.ginsberg@varian.com

Web Site: http://www.varian.com/

Siemens' Donation of Digital Radiography System Benefits Children's Health FundOnline Auction Winner John T. Mather Memorial Hospital Presents CHF with check for $285,000

PORT JEFFERSON, N.Y., Sept. 18 /PRNewswire-FirstCall/ -- With a click of a button, the lives of thousands may have changed for the better. As the winning online bidder for a Siemens Healthcare digital radiography (DR) system, John T. Mather Memorial Hospital (http://www.matherhospital.org/) in Port Jefferson, N.Y., today presented a check for $285,309 to the Children's Health Fund (CHF) (http://www.childrenshealthfund.org/), a national organization dedicated to providing health care for homeless and medically disadvantaged children and advocating on behalf of all children. Mather Hospital's new Siemens DR system, the Ysio , will allow the hospital to comfortably image patients of various shapes and sizes, ages and disabilities.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"We are extremely grateful to Siemens Healthcare for selecting the Children's Health Fund to benefit from the online auction of the Ysio and to Mather Hospital for making the important purchase," stated Karen Redlener, executive director, Children's Health Fund. "The funds donated will be used to support CHF programs and urgently needed health and mental health services for children and families across the nation, needed now more than ever due to these tough economic times."

In December 2008, Siemens donated a new Ysio to the CHF, which, in turn, posted the digital X-ray system online, enabling hospitals to bid in an online auction over a two-week period, just prior to the holidays. All proceeds from the event benefit CHF* to further support the non-profit organization's work with underserved children and their families throughout the country, while the winning hospital can better serve its community with a DR system for virtually all their clinical demands.

Online auction bidding took place December 8-18, 2008. The starting bid for the Ysio was $99,999. (The system's list price is $450,000.)

"Mather Hospital is proud and privileged to be part of this worthy project, which supports the mission of Children's Health Fund and brings the latest in X-ray technology to our community," said Mather Hospital President Kenneth Roberts. "Siemen's digital radiology system's advanced features will allow our physicians and hospital staff to provide an even higher level of personalized care and service."

The newly installed Ysio will enable Mather Hospital to use the DR system as an integrated command center by controlling their workflow from registration to image data management. With more than 500 different preset examination positions, Ysio can save preparation time and effort. Simply pressing a button on the wireless remote will automatically move the X-ray tube into position.

"Corporate responsibility remains a focus for Siemens even during difficult times like these when healthcare and other economic issues are weighing heavily on everyone's minds," said Claus Grill, vice president, Cardiac, Interventional/Neuro and X-ray Systems, Siemens Healthcare. "Innovations, such as the Ysio, contribute to the health and well-being of people throughout the world, while improving operational efficiencies and optimizing workflow."

Ysio's wireless detector (wi-D) handles like a cassette and can be removed from the table and placed directly underneath or next to the patient for exposures that are difficult or impossible to take using a fixed detector. As a digital radiography solution, Ysio delivers pristine image quality with high-resolution images available within seconds of acquisition. Images acquired with the wi-D can be previewed in as little as five seconds without the need to change or process cassettes.

Ysio's ergonomic table design caters to the full spectrum of patient profiles from pediatrics to bariatrics, offering a 660-pound weight capacity and a low table height of 21 inches for convenient positioning when shifting sick or elderly patients from wheelchair to table.

Founded in 1987 by singer/songwriter Paul Simon, and pediatrician/advocate Dr. Irwin Redlener, the Children's Health Fund is committed to providing health care to the nation's most medically under-served children and their families through the development and support of innovative medical programs, response to public health crises, and the promotion of guaranteed access to appropriate health care for all children. CHF partners with major academic medical centers to deliver health care to disadvantaged children and families, via state-of-the-art mobile medical clinics, in both rural and urban areas across the country.

*Acceptance of the proceeds of this auction does not constitute an endorsement of the Ysio by the Children's Health Fund.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source -- from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: http://www.siemens.com/healthcare.

Photo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com Siemens Healthcare

CONTACT: Media Relations, Tom Schaffner of Siemens Medical Solutions
USA, Inc. Healthcare Sector - Imaging & IT Division, +1-610-448-1477,
thomas.schaffner@siemens.com

Web Site: http://www.siemens.com/healthcare

Community Valley Bancorp Announces Voluntary Delisting of Its Common Stock

CHICO, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Community Valley Bancorp, , the holding company for Butte Community Bank, announced today that it has given formal written notice to the NASDAQ Stock Market ("NASDAQ") of the Company's intention to voluntarily delist its common stock from the NASDAQ Capital Market. The Company also announced it intends to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company currently anticipates that it will file a Form 25 with the Securities and Exchange Commission ("SEC") and NASDAQ relating to the delisting and deregistration of its common stock on or about September 28, 2009. As a result, the Company expects that the last day of trading of its common stock on the NASDAQ Capital Market will be at the close of trading on September 25, 2009.

The decision to delist has been reached as part of the Company's overall strategy to conserve resources and improve cost-effectiveness as the benefits of maintaining a NASDAQ listing have not materialized. Considering the limited trading volume and low trading prices on NASDAQ, the Company has concluded a listing on NASDAQ does not justify the expense and administrative burden associated with maintaining such listing.

Following the delisting, the Company anticipates that its common stock will be quoted on the OTC Bulletin Board, a centralized electronic quotation service for over-the-counter securities, so long as market makers demonstrate an interest in trading in the Company's common stock. However, the Company can give no assurance that trading in its common stock will continue on any securities exchange or quotation medium. The Company will continue to file periodic and other reports with the SEC as the Company's common stock will remain registered under Section 12(g) of the Exchange Act.

About Community Valley Bancorp

Community Valley Bancorp is the parent company of Butte Community Bank, a progressive Northern California bank that combines traditional deposit and lending services with innovative banking solutions, and Butte Community Insurance Agency, LLC, a full service insurance agency offering all lines of coverage from auto and health to commercial and farm packages.

Founded in 1990, Butte Community Bank is a California state-chartered bank with 15 branches in eleven cities including Anderson, Chico, Colusa, Corning, Magalia, Oroville, Paradise, Red Bluff, Redding, Yuba City and Marysville. It also operates a loan production office in Citrus Heights. Community Valley Bancorp is headquartered in Chico, California.

For more information visit: http://www.communityvalleybancorp.com/ Safe Harbor

The matters discussed herein may consist of forward-looking information under the Private Securities Litigation Reform Act of 1995. The accuracy of the forward-looking information is necessarily subject to and involves risk and uncertainties, which could cause actual results to differ materially from forward-looking information. For a detailed description of factors that could cause or contribute to such differences, please see our filings with the Securities and Exchange Commission.

When used in this release, the words "believes," "estimates," "plans," "expects," "should," "will," "may," "might," "outlook," "likely," and "anticipates" or similar expressions as they relate to Community Valley Bancorp (including its subsidiaries), or its management are intended to identify forward-looking statements. Although we believe that the assumptions underlying the forward-looking information are reasonable, any of the assumptions could prove to be inaccurate. Therefore, we can give no assurance that the results contemplated in the forward-looking information should not be construed as a representation by the Company or any person that future events, plans, or expectations contemplated by the Company will be achieved. We undertake no obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events, or otherwise.

The Company, from time to time, becomes aware of rumors concerning the Company or its business. As a matter of policy, the Company does not comment on rumors. Investors are cautioned that in this age of instant communication and Internet access, it may be important to avoid relying on rumors and unsubstantiated information regarding the Company. The Company complies with Federal and State law applicable to disclosure of information concerning the Company. Investors may be at significant risk in relying on unsubstantiated information from other sources.

Community Valley Bancorp

CONTACT: John Coger of Community Valley Bancorp, +1-530-899-7100, ext.
3354, jcoger@buttecommunity.com

Web Site: http://www.communityvalleybancorp.com/

ActionView International, Inc. Announces Promotion of MatchFights Events Through Twitter Accounts

MURRIETA, Calif., Sept. 18 /PRNewswire-FirstCall/ -- ActionView International, Inc. (Pink Sheets: AVEW) and its wholly owned MatchFights, LLC subsidiary today announced that fans of MatchFights should follow the company on Twitter. ActionView Director Tony "The Tiger" Lopez, a 3-time world boxing champion, will provide updates on his activities related to Action and MatchFights on his Twitter account, which can be found under the name "1boxer63." MatchFights also has a Twitter account, which can be found under the name "preacherBKB."

Mr. Lopez, who, along with his role as director of ActionView International, is actively involved in the promotion and marketing of MatchFights events, including the premier September 25, 2009 broadcast, has already begun encouraging followers of his Twitter account to visit the event website, http://www.bkbfightclub.com/ and register to view the first fight. The first live event, which will be delivered in an interactive venue over the Internet to a global audience, will feature fourteen fighters from a broad fight background including MMA, Muy Thai, boxing and street fighting.

"Twitter and other social networking sites are just one part of MatchFights' comprehensive marketing and promotional strategy," commented Gary Nerison, chairman of ActionView International. "As we grow the brand, there should be no marketing channel that we will not utilize, including print, radio and television. Our core demographic is the fight fan, but there are countless ways to reach that audience as well as other sports fans who are not interested in the more traditional boxing or MMA products, but who will be drawn in by the unique elements of MatchFights events, including contrasting styles of the fighters and the interactive features of our live broadcasts."

Mr. Lopez said, "Having been at the world championship level of professional boxing as a fighter and now as a fight promoter, I understand the importance of effective promotion. I plan to use every appropriate resource at my disposal to bring attention to MatchFights events, and I hope anyone interested in the company or our events will follow my Twitter postings. They will range from updates on the pre-fight planning, updates on the event as they unfold and my thoughts after each event is concluded.

Fight fans interested in watching the MatchFights event live via the Internet can pre-register for $9.95 at http://www.bkbfightclub.com/. Tickets for the event are available by contacting http://www.bkbfightclub.com/ and through several local retailers in Evanston. The pre-fight weigh in will be at 12:30 local time on September 25, 2009 at Suds Brothers Brewery located at 1012 Main Street in Evanston.

For this inaugural MatchFights event, all subscribers have their names entered into a drawing, and winners will receive a year of free subscriptions to MatchFights pay-per-view events. MatchFights is planning to hold its events approximately every 45 days, so winners will receive free pay-per-view subscriptions to 8 additional events throughout the year.

The company encourages shareholders and anyone interested in following the progress of ActionView International and its wholly owned MatchFights, LLC subsidiary to subscribe to the mailing list at http://www.matchfights.com/.

About ActionView International, Inc.

ActionView International has completed its acquisition of MatchFights, LLC, which is now the focus of the company's operations. MatchFights, LLC and its BKB Fight Club property deliver live, high definition, pay-per-view events, including no-holds-barred, full contact fights, in an interactive venue over the Internet to a global audience. MatchFights intends to sanction events and ultimately create BKB champions that are recognized worldwide. The live events will have broad appeal and include elements of fighting, music, ring girl contests, and other live entertainment as part of the broadcast. The premier BKB Fight Club event will take place on September 25, 2009. For additional information about MatchFights and its BKB Fight Club, please visit http://www.matchfights.com/ or http://www.bkbfightclub.com/.

Forward-Looking Statements

This release contains 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be 'forward-looking statements.' Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.

Contact: ActionView International, Inc. Investor Relations 951-200-4107 media@matchfights.com

ActionView International, Inc.

CONTACT: Investor Relations of ActionView International, Inc.,
+1-951-200-4107, media@matchfights.com

Web Site: http://www.matchfights.com/

Pcubed Works With Microsoft to Successfully Launch Office, Visio, Project, and SharePoint

PHOENIX, September 18 /PRNewswire/ --

The Microsoft Wave 14 Launch team is tasked to coordinate and execute a successful launch of Office, Visio, Project, and SharePoint within the United States. The expectation is to do more with less, driving launch activities through existing operating models and marketing engines -- balancing the independent needs of a broad group of stakeholders, addressing increased competition, and ensuring alignment and synchronization with world-wide strategies.

To address these challenges, the Information Worker (IW) Business and Marketing Organization (BMO) identified an experienced Product Manager to lead the launch and engaged Pcubed(R) to set up a Launch Program Management Office (PMO) to guide planning and execution of launch activities. This Launch team is leveraging the following approach to drive a successful launch.

"The ability to successfully manage a complex set of activities under tight deadlines and a constraint budget has never been more important than today. As Microsoft is readying the most significant version of Microsoft Project in a decade together with the Office 2010 release, it is exciting to see Pcubed lend its expertise to help plan and execute the Office launch effort using Project," Ludovic Hauduc, General Manager for Microsoft Office Project.

Building a Comprehensive Launch Plan

A marketing-focused program and project management framework is in place and guiding launch plan definition across the three launch work streams. This consistent framework enables integration across launch plans and effective communications across all stakeholders.

Targeting Business-focused Results

Clearly defined business-focused objectives are in place to drive overall launch delivery effectiveness. This enables definition of a portfolio that represents marketing activities across the three launch work streams. Portfolio visibility is supported through an integrated master schedule in Microsoft Project Server. The Launch team guides optimization of the marketing mix during launch - identifying gaps, overlaps, conflicts, etc., and answering the question: Are we doing the right things?

Driving Effective Delivery

With a significantly smaller budget than past launches, launch execution is dependent on coordinating efforts across stakeholders and leveraging existing operating model and engines. Key activities are infused from a limited launch budget to optimize marketing impact. Execution timing is critical - launch activities must be in market at a certain time for them to drive maximum results. The Launch team will guide oversight of launch delivery execution, answering the question: Are we doing things right?

"This launch is a large complex business initiative with a finite set of deliverables requiring collaboration with a vast number of people across the organization. We are excited to be taking a project management focused approach and using Microsoft Project technology to help deliver a successful launch and achieve our business objectives." Julie Sanford, US Launch Program Manager, Microsoft US IW BMO Group.

About Microsoft

Founded in 1975, Microsoft (Nasdaq: MSFT) is the worldwide leader in software, services and solutions that help people and businesses realize their full potential.

About Pcubed

Pcubed (Program Planning Professionals Inc.) is the global specialist in portfolio, program and enterprise project management, we partner with top organizations delivering results through tailor-made solutions to fit each enterprise culture and individual need.

For more information, visit www.pcubed.com.

Pcubed

Carl Dalby, Vice President - Marketing of Pcubed, +44(0)207-462-0100, carl.dalby@pcubed.com